Cargando…

Diabetes Mellitus and the Benefit of Antiresorptive Therapy on Fracture Risk

Type 2 diabetes (T2D) is associated with increased risk of fractures. However, it is unclear whether current osteoporosis treatments reduce fractures in individuals with diabetes. The aim of the study was to determine whether presence of T2D influences the efficacy of antiresorptive treatment for os...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eastell, Richard, Vittinghoff, Eric, Lui, Li‐Yung, Ewing, Susan K., Schwartz, Ann V., Bauer, Douglas C., Black, Dennis M., Bouxsein, Mary L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092457/ https://www.ncbi.nlm.nih.gov/pubmed/36065588 http://dx.doi.org/10.1002/jbmr.4697

Ejemplares similares

Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH‐ASBMR SABRE Project
por: Eastell, Richard, et al.
Publicado: (2021)

Antiresorptive Versus Anabolic Therapy in Managing Osteoporosis in People with Type 1 and Type 2 Diabetes
por: Vilaca, Tatiane, et al.
Publicado: (2023)

Benefits of combined treatments using antiresorptive agents and cytotoxic drugs
por: Holen, I, et al.
Publicado: (2006)

Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis
por: Tanaka, Makoto, et al.
Publicado: (2017)

Romosozumab and antiresorptive treatment: the importance of treatment sequence
por: Cosman, Felicia, et al.
Publicado: (2022)

Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragility
por: Kittithaworn, Annop, et al.
Publicado: (2023)

New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015)

Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty
por: Tseng, Y.-Y., et al.
Publicado: (2011)

Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women’s health practice
por: Cheung, Angela M, et al.
Publicado: (2016)

Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis
por: Ota, Seiya, et al.
Publicado: (2016)

THU435 Atypical Femur Fractures In Antiresorptive- Therapy-naïve Patient Underscores Knowledge Gaps
por: Gray Cater, Taylor Lauren, et al.
Publicado: (2023)

Persistent Bilateral Atypical Femoral Fractures in an Antiresorptive-Naïve Singaporean Chinese Patient with Graves’ Disease*
por: Choo, Kuan Swen, et al.
Publicado: (2023)

The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy
por: Kincse, Gyöngyvér, et al.
Publicado: (2012)

Sex‐ and Age Group‐Specific Fracture Incidence Rates Trends for Type 1 and 2 Diabetes Mellitus
por: Nasser, Mohamad I, et al.
Publicado: (2023)

Antiresorptive-associated spontaneous fractures of both tibiae, followed by an atypical femur fracture during the sequential treatment with alendronate, denosumab then teriparatide
por: Tan, Juan, et al.
Publicado: (2019)

Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy
por: Leder, Benjamin Z
Publicado: (2018)

The Relationship Between Bisphosphonate Adherence and Fracture: Is It the Behavior or the Medication? Results From the Placebo Arm of the Fracture Intervention Trial
por: Curtis, Jeffrey R, et al.
Publicado: (2011)

Synergistic effects of cytotoxic drugs and antiresorptive agents in vitro and in vivo
por: Ottewell, PD, et al.
Publicado: (2006)

Medication burden of Saudi Arabian women receiving antiresorptive therapy
por: Sadat-Ali, Mir, et al.
Publicado: (2012)

Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents
por: Rodriguez-Lozano, Francisco-Javier, et al.
Publicado: (2016)

Gingival cell growth with antiresorptive treatment combined with corticosteroids or antiestrogen
por: Ekholm, Heidi M., et al.
Publicado: (2021)

Composition and Properties of Saliva in Patients with Osteoporosis Taking Antiresorptive Drugs
por: Sobczak-Jaskow, Hanna, et al.
Publicado: (2023)

The low and disproportionate utilization of antiresorptive therapy in patients with osseous metastasis
por: Agarwal, Amil R., et al.
Publicado: (2023)

Effectiveness of antiresorptive medications in women on long-term dialysis after hip fracture: A population-based cohort study
por: Lin, Yu-Ciou, et al.
Publicado: (2020)

FRI675 Higher FSH Level Is Associated With Increased Risk Of Incident Hip Fracture In Older Adults, Independent Of Sex Hormone Levels
por: Koh, Eileen H, et al.
Publicado: (2023)

Importance of antiresorptive therapies for patients with bone metastases from solid tumors
por: Talreja, Draupadi B
Publicado: (2012)

Antiresorptive Activity of Bacillus-Fermented Antler Extracts: Inhibition of Osteoclast Differentiation
por: Choi, Sik-Won, et al.
Publicado: (2013)

Disulfiram Attenuates Osteoclast Differentiation In Vitro: A Potential Antiresorptive Agent
por: Ying, Hua, et al.
Publicado: (2015)

Dental care for patients taking antiresorptive drugs: a literature review
por: Song, Minju
Publicado: (2019)

Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw
por: Kim, Ha Young
Publicado: (2021)

Pharyngeal spreading of peri-implant infections under antiresorptive/antiangiogenic therapy
por: Kern, Karsten, et al.
Publicado: (2021)

Analysis of Serum Proteome after Treatment of Osteoporosis with Anabolic or Antiresorptive Drugs
por: del Real, Alvaro, et al.
Publicado: (2022)

Use and risk of side effects of antiresorptive medication in people with intellectual disabilities
por: Frighi, Valeria, et al.
Publicado: (2022)

Antiresorptive treatment and talar collapse after displaced fractures of the talar neck: a long-term follow-up of 19 patients
por: Meunier, Andreas, et al.
Publicado: (2021)

Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals
por: Cosman, Felicia, et al.
Publicado: (2021)

Serotonin reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local antiresorptive effect
por: Ortuño, María José, et al.
Publicado: (2016)

Dental implants in patients treated with antiresorptive medication – a systematic literature review
por: Walter, Christian, et al.
Publicado: (2016)

Anabolic and antiresorptive actions of locally delivered bisphosphonates for bone repair: A review
por: Qayoom, I., et al.
Publicado: (2018)

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
por: Taguchi, Akira, et al.
Publicado: (2017)

Antiresorptive medication in oncology: the clinical and dental profile of patients in a reference center
por: Ferreira, Vitor Hugo Candido, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pse1rarlkk4pjblepp18bsdfli